Tuesday, August 12, 2025, 2:00 pm EDT
The prevalence of mood disorders has risen in recent years while help-seeking behaviors (either medication or talk therapy) has remained consistently low. This webinar will present recent scientific advances to improve the efficacy of psychosocial treatments for mood and psychotic disorders. The audience will learn about the strengths and weaknesses of current psychotherapies for mood disorders. Two methods currently being investigated by Dr. Weintraub to improve psychotherapies for mood disorders will be discussed: (1) a mobile app used as an adjunct to therapy for adolescents at risk for mood disorders; and (2) psilocybin as an adjunct to psychotherapy for adults with major depression.
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Sign up for other upcoming webinars.
View past webinar recordings.
Presented by
Assistant Professor of Psychiatry
UCLA Semel Institute for Neuroscience and Human Behavior
2023 Young Investigator Grant
Dr. Marc Weintraub is an Assistant Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA. His research interests involve the course, risk factors, and psychosocial treatment of mood and psychotic disorders. His recent research has focused on methods to improve the efficacy of psychosocial treatments for mood and psychotic disorders. Dr. Weintraub developed a multi-family cognitive-behavioral therapy (CBT) for adolescents at high risk for mood and psychotic disorders, and received a career development award from the National Institute of Health to examine how a mobile app can improve the acceptability and adherence to the treatment. With funding from BBRF, Dr. Weintraub’s team is studying CBT as an adjunct for psilocybin treatment to treat major depressive disorder in adults.
Moderated by
Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
